/Companies

Atalanta

41 employees on LinkedIn · 9 known investors

Find your way into Atalanta

Sign up to see every warm intro you have to Atalanta

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Atalanta team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology. The company was founded by leading experts in RNAi research.

Investors · 9

Also in the syndicate · 3

GHR FoundationMirae Asset Financial GroupPictet Alternative Advisors

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Atalanta do?
Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology. The company was founded by leading experts in RNAi research.
Who are Atalanta's investors?
Atalanta's investors include F-Prime Capital, Novartis Venture Fund, RiverVest Venture Partners, Sanofi Ventures, abrdn plc, EQT Life Sciences.